Journal article

Protein-chemical standardization of the erythrocyte glutathione reductase activation test (EGRAC test) - Application to hypothyroidism


Authors listBecker, K; Krebs, B; Schirmer, RH

Publication year1991

Pages180-187

JournalInternational Journal for Vitamin and Nutrition Research

Volume number61

Issue number2

ISSN0300-9831

eISSN1664-2821

PublisherHogrefe


Abstract
The erythrocyte glutathione reductase activation coefficient (EGRAC) is an index of riboflavin deficiency or, more exactly, of FAD deficiency in man. In this report a sensitive version of the EGRAC test is introduced that is based on the molecular properties of glutathione reductase and its FAD-free apoenzyme. The hemoglobin concentration of the blood sample can be estimated simultaneously using the spectrophotometric absorption at 340 nm. - The method was tested for 33 thyroidectomized patients in comparison with a euthyroid control group. From the average EGRAC values (1.40 vs. 1.22) it was deduced that the average free FAD level was approximately 2 times lower for the patients' than for the control group. Discussed is the role of the EGRAC test in hormonal and nutritional disorders.



Citation Styles

Harvard Citation styleBecker, K., Krebs, B. and Schirmer, R. (1991) Protein-chemical standardization of the erythrocyte glutathione reductase activation test (EGRAC test) - Application to hypothyroidism, International Journal for Vitamin and Nutrition Research, 61(2), pp. 180-187

APA Citation styleBecker, K., Krebs, B., & Schirmer, R. (1991). Protein-chemical standardization of the erythrocyte glutathione reductase activation test (EGRAC test) - Application to hypothyroidism. International Journal for Vitamin and Nutrition Research. 61(2), 180-187.


Last updated on 2025-21-05 at 15:54